摘要 |
The present invention provides compounds which promote erythropoietin production. Compounds represented by the following general formula (1) or pharmacologically acceptable salts thereof are provided: (see formula 1) [wherein, R1 represents a group -X-Q1, X-Q1-Y Q2 or -X-Q1-Y Q2-Z-Q3, X represents a single bond, -CH2- or the like, Q1 represents a monocyclic or bicyclic heterocyclic group which may have substituent(s), Y represents a single bond, -CH2-, or the like, Q2 represents a monocyclic or bicyclic hydrocarbon ring group which may have substituent(s) or a monocyclic or bicyclic heterocyclic group which may have substituent(s), Z represents a single bond, -CR11R12- or the like, R11 and R12 each independently represents a hydrogen atom, a halogen atom or the like, Q3 represents a phenyl group which may have substituent(s), a C3-C7 cycloalkyl group which may have substituent(s), a C3-C7 cycloalkenyl group which may have substituent(s) or a monocyclic or bicyclic heterocyclic group which may have substituent(s), R2 represents a C1-C3 alkyl group or the like, and R3 represents a hydrogen atom or a methyl group].
|
申请人 |
DAIICHI SANKYO COMPANY, LIMITED |
发明人 |
KURIBAYASHI, TAKESHI;KUBOTA, HIDEKI;FUKUDA, TAKESHI;TAKANO, RIEKO;TSUJI, TAKASHI;SASAKI, KOJI;TANAKA, NAOKI |